Founded in 2006, Wolfestone Group is a leading language services provider offering a powerful combination of AI-driven and human-led solutions. We deliver translation, interpreting, transcription, linguistic validation, subtitling and more, designed to help organisations communicate clearly and confidently across global markets. We proudly serve a diverse range of industries, including life sciences, biotechnology, and clinical trials. Our services ensure linguistic precision, regulatory compliance, and cultural sensitivity. Wolfestone is ISO-certified for quality management (ISO 9001), translation services (ISO 17100), and information security (ISO 27001), offering complete confidence in our reliability, confidentiality and quality.
WIENER LAB.
We develop, manufacture and market integrated solutions that enable IVD diagnostics in more than 50 countries around the world. We offer a broad line of products for clinical laboratories and blood banks that enable accurate and timely diagnoses. We generate key and relevant information for medical decision making, understanding the laboratory as a crucial link in the health chain. | We develop, manufacture and market integrated solutions that enable IVD diagnostics in more than 50 countries around the world. We offer a broad line of products for clinical laboratories and blood banks that enable accurate and timely diagnoses. We generate key and relevant information for medical decision making, understanding the laboratory as a very important player in the health system. | Wiener lab. is an innovation-driven multinational from Argentina, with over six decades of experience in the in vitro diagnostics (IVD) industry. With a presence in more than 50 countries, the company continues to grow across Latin America, South Asia, and Europe. Its mission is to deliver smart, reliable, and accessible diagnostic solutions for healthcare systems worldwide. At the heart of its innovation engine is the Centre for Research and Biotechnology (CIBio), where a diverse team of scientists and engineers leads the development of new technologies. The company promotes open innovation by fostering strategic partnerships with academic institutions, regulatory bodies, and clinical collaborators. Wiener lab. actively seeks global partners for OEM manufacturing, technology transfer, and co-development projects. These collaborations are essential for enhancing technological capabilities and providing quicker, more adaptable solutions to meet evolving healthcare demands. The product portfolio includes clinical chemistry, molecular biology, hematology, hemostasis, immunology, urinalysis, chemiluminescence, and ESR, all developed in certified manufacturing facilities that comply with ISO and FDA requirements.
Wales Cymru (Welsh Government)
Wales is a self-governing country of the UK and the Welsh Government is the devolved Government for Wales. The Welsh Government’s decision-making powers within a small and joined-up country mean we can act fast. They also mean we are responsible for our own economic development, so you won’t find a more pro-business Government anywhere. Wales has a strong industrial heritage that has shaped our confident, creative and ambitious economy of today. Wales means business.
Viscadia
Viscadia is a leading global forecasting firm that empowers the life sciences industry with clarity and confidence through forecasting. With a team of forecasting specialists and a commitment to excellence, we leverage our expertise to design and build custom models, execute market research to frame the business case and ask the right questions, and optimize decision-making through ongoing comprehensive cycle support. To learn more, visit www.viscadia.com. | Forecasting specialists for the life sciences industry. Our comprehensive, dynamic and clear forecasts drive optimized business planning and execution around the globe. We leverage decades of experience to deliver custom forecast models that establish a solid foundation for accurately projecting product performance and they are agile, allowing for real-time scenario planning as the market landscape changes. With teams in the United States, Switzerland, and India, we are well-equipped to provide the support global pharmaceutical and biotechnology companies need to make decisions quickly and with confidence.
Vettiva Saúde Animal
Vettiva Animal Health is a biotech startup focused exclusively on Research and Development (R&D) and commercialization of innovative pharmaceuticals derived from Medical Cannabis. It is also the first company to formalizeclinical development of cannabidiol-based veterinary candidate therapies with the Brazilian Ministry of Agriculture, Livestock, and Supply (MAPA).
Venture Valuation AG/Biotechgate
Venture Valuation specializes in independent asset and company valuation of biotechnology, biopharma, life sciences and medical technology. Valuations are provided for fundraising, investment decision, portfolio valuations, in- and out-licensing, arbitration/fairness opinions and M&A. The company has developed “Biotechgate”, which is business development and licensing database for the life sciences industry. Company Valuation: The Company Valuation Reports include a thorough assessment of the company by experienced professionals with expertise in the relevant fields as well as the following elements: • summary of key risk parameters and strengths of the company • outline of the crucial factors and value drivers for growth and further strategic development • assessment of the management, market, science, technology and products • analysis of the company’s business model and the company’s competitive environment • detailed calculation of the company’s financial value, using appropriate valuation methods Product Valuation: Venture Valuation offers detailed Product Valuation Reports of pre-clinical and clinical products in development that can serve as a basis for negotiations or to structure different deal scenarios. The Product Valuation includes: • detailed analysis of development costs, time lines, patient population, competing products, pricing and product life cycle • industry gold standard rNPV valuation methodology based on indication-specific attrition rates and the development stage • scenario and sensitivity analyses • analysis of the current value, and forecasts of the future value following the successful completion of key development milestones As an “add on” module and based on Venture Valuation’s deal database within Biotechgate, benchmarking deals can also be included to provide the client with a differentiated negotiation basis and comparable information.
Uniphar
Uniphar Group is a trusted global partner to pharma, medtech and biotech companies, working to improve patient access to medicines around the world. Uniphar’s team of experts harness the capabilities, infrastructure and expertise of a diversified pharmaceutical service provider with more than 57 years’ building success stories with 200+ multinational clients. Our understanding of the shifting market dynamics allows us to deliver tailored specialist services and solutions for our clients’ changing needs. Uniphar Pharma comprises of Uniphar | Clinical & Development, Uniphar | Access, Uniphar | Medical, and Uniphar | Commercial – together our combined capabilities make us your trusted partner to unlock access for your patients to innovative therapies and optimize value for brands globally. Partnering from clinical development to commercialisation, Uniphar’s global presence and in-depth market expertise remove barriers to launch and enhance pathways to life changing therapies. Connecting the dots from molecule to market.
Thrivable
Thrivable leverages deep expertise in diabetes and obesity to support the entire drug development and commercialization lifecycle–delivering patient insights to drive market research and accelerating clinical trial enrollment with immediate access to qualified patient populations for a faster path to FDA approval. To learn more, visit thrivable.app.
That’s Nice
That’s Nice is a full-service agency providing research-driven marketing and brand management to companies within the life sciences. Our integrated offering reflects 30 years of industry knowledge, a passion for strategic thinking, and a comprehensive approach that meets the needs of global companies. We advise clients on all aspects of brand development, promoting engagement through our industry-leading research, strategy, design and business services.
Swiss Business Hub USA
The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location. The Swiss Business Hub USA provides localized support, market information, consulting and networking services to Swiss companies venturing into the US market. In addition, the Swiss Business Hub actively promotes Switzerland as a highly attractive business and investment location for US companies looking for growth in Switzerland and in Europe. The Swiss Business Hub proactively contacts and informs US-based companies about the key advantages of Switzerland as a business and investment location. The Swiss Business Hub USA has a first-rate network of contacts both in the US and in Switzerland. | The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location.